University Of Tasmania
Browse

File(s) under permanent embargo

Endothelial to mesenchymal transition (EndMT) and vascular remodeling in pulmonary hypertension and idiopathic pulmonary fibrosis

journal contribution
posted on 2023-05-20, 18:23 authored by Archana GaikwadArchana Gaikwad, Mathew Eapen, McAlinden, KD, Chia, C, Josie LarbyJosie Larby, Stephen MyersStephen Myers, Dey, S, Haug, G, Markos, J, Glanville, AR, Sukhwinder SohalSukhwinder Sohal

Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and irreversible fibrotic disease associated with respiratory failure. The disease remains idiopathic, but repeated alveolar epithelium injury, disruption of alveolar-capillary integrity, abnormal vascular repair, and pulmonary vascular remodeling are considered possible pathogenic mechanisms. Also, the development of comorbidities such as pulmonary hypertension (PH) could further impact disease outcome, quality of life and survival rates in IPF.

Areas covered: The current review provides a comprehensive literature survey of the mechanisms involved in the development and manifestations of IPF and their links to PH pathology. This review also provides the current understanding of molecular mechanisms that link the two pathologies and will specifically decipher the role of endothelial to mesenchymal transition (EndMT) along with the possible triggers of EndMT. The possibility of targeting EndMT as a therapeutic option in IPF is discussed.

Expert opinion: With a steady increase in prevalence and mortality, IPF is no longer considered a rare disease. Thus, it is of utmost importance and urgency that the underlying profibrotic pathways and mechanisms are fully understood, to enable the development of novel therapeutic strategies.

History

Publication title

Expert Review of Respiratory Medicine

Volume

14

Issue

10

Pagination

1027-1043

ISSN

1747-6348

Department/School

School of Health Sciences

Publisher

Taylor & Francis

Place of publication

United Kingdom

Rights statement

Copyright 2020 Informa UK Limited, trading as Taylor & Francis Group

Repository Status

  • Restricted

Socio-economic Objectives

Clinical health not elsewhere classified